PharmaTimes: News RSS

Digital tech has health benefits for dementia patients, project finds

Wed, 23 Sep 2020 08:57:32 GMT

The Leeds Dementia Pathfinder project supported patients and carers with tech devices

Owlstone Medical’s breath biopsy test improves detection of liver disease

Wed, 23 Sep 2020 08:57:20 GMT

Study detected Nonalcoholic Fatty Liver Disease and Nonalcoholic steatohepatitis

Vertex, CRISPR Therapeutics’ sickle cell gene therapy wins PRIME designation

Wed, 23 Sep 2020 08:57:08 GMT

European Medicines Agency grants designation based on phase I/II data

Sanofi, GSK ink deal with EU for 300 million COVID-19 vaccine doses

Wed, 23 Sep 2020 08:55:51 GMT

Upfront funding will be used to scale-up manufacturing

Bristol Myers Squibb’s Opdivo shows benefit in oesophageal cancers

Tue, 22 Sep 2020 08:57:03 GMT

Data presented at 2020 ESMO virtual congress

Roche acquires Irish biotech firm Inflazome

Tue, 22 Sep 2020 08:56:50 GMT

Swiss pharma company to acquire biotech for $449m (€380m)

GSK’s Zejula and AZ’s Lynparza leap toward broader EU approval

Tue, 22 Sep 2020 08:56:33 GMT

Both PARP inhibitors receive positive opinions from CHMP

UK’s chief medical officers upgrade coronavirus alert level

Tue, 22 Sep 2020 08:55:58 GMT

Decision made following review of rising COVID-19 cases

Keytruda/Lenvima combo shows promise in hard-to-treat cancers

Mon, 21 Sep 2020 08:42:49 GMT

Data shows a range of responses in different tumours

University of Edinburgh spinout Cellinta will develop gene therapies for cancer

Mon, 21 Sep 2020 08:41:59 GMT

Investors include SV Health Investors and Cancer Research UK

Lynparza scores long-term benefit data in BRCA-mutated ovarian cancer

Mon, 21 Sep 2020 08:41:27 GMT

Detailed results presented at ESMO also show benefit in prostate cancer

CHMP backs seven new meds in September meeting

Mon, 21 Sep 2020 08:40:45 GMT

Positive opinions include Pacira's Exparel and two new vaccines from Sanofi

BMS' Opdivo wins new NICE lung cancer backing

Fri, 18 Sep 2020 08:40:42 GMT

The drug has been approved for routine NHS commissioning for squamous or non-squamous NSCLC

Bayer’s Vitrakvi shows long-term efficacy in TRK fusion-positive cancers

Fri, 18 Sep 2020 08:37:55 GMT

Tumour agnostic therapy demonstrates sustained efficacy

Access to coronavirus tests should be ‘top priority’, says NHS Confederation director

Fri, 18 Sep 2020 08:37:17 GMT

Concerns over NHS Test and Trace system exacerbated by continuing rise in cases

NICE u-turn sees Akcea's Waylivra win NHS funding

Fri, 18 Sep 2020 08:36:40 GMT

The drug is the first and only therapy for the ultra rare condition Familial Chylomicronaemia Syndrome (FCS)

IVD industry must be supported in COVID-19 recovery strategy, says BIVDA

Thu, 17 Sep 2020 09:29:42 GMT

Industry body says in vitro diagnostics are vital to clearing the backlog of undiagnosed conditions

Novartis’ Tafinlar plus Mekinist shows long-term benefit in advanced melanoma

Thu, 17 Sep 2020 09:29:28 GMT

Over half of patients treated with combination therapy were alive and relapse-free after five years

AZ picks up oral PCSK9 inhibitor programme from Dogma

Thu, 17 Sep 2020 09:29:14 GMT

AZ will take the programme forward into clinical development

Lilly’s COVID-19 antibody shows promise in mid-stage study

Thu, 17 Sep 2020 09:28:51 GMT

Middle dose tested hit the primary endpoint of the Phase II trial